(Q43990754)

English

HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

Louis M Havekes

5

object named as

Louis M Havekes

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Richard Draijer

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Oscar L Volger

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Vivian E H Dahlmans

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Elly C M de Wit

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hans M G Princen

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1755-1761

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Novel approaches to lipid lowering: what is on the horizon?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Therapeutic potential of plant sterols and stanols

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Cholesterol lowering action of HOE 402 in the normolipidemic and hypercholesterolemic golden Syrian hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

Hypolipidemic activity of HOE-402 is mediated by stimulation of the LDL receptor pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900898-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(02)00898-5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43990754&oldid=2105372490"